Asset Details
Do you wish to reserve the book?
EP1028 Metastatic patterns do not provide additional prognostic information in patients with FIGO stage IV high-grade serous ovarian cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
EP1028 Metastatic patterns do not provide additional prognostic information in patients with FIGO stage IV high-grade serous ovarian cancer
Do you wish to request the book?
EP1028 Metastatic patterns do not provide additional prognostic information in patients with FIGO stage IV high-grade serous ovarian cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
EP1028 Metastatic patterns do not provide additional prognostic information in patients with FIGO stage IV high-grade serous ovarian cancer
2019
Overview
Introduction/BackgroundThe aim of our study was to investigate whether metastatic patterns were associated with prognosis in patients with FIGO stage IV high-grade serous ovarian cancer (HGSC).MethodologyWe retrospectively investigated FIGO stage IV HGSC patients who underwent primary staging or debulking surgery between April 2005 and June 2013 at our institution. None of these patients received neoadjuvant chemotherapy. Metastatic patterns were defined as pleural effusion (stage IVA), parenchymal metastases (stage IVB), and extra-abdominal lymph node metastases (stage IVB). Clinical characters and metastatic patterns were compared with chi-squared or Fisher’s exact tests as appropriate. Overall survival was analyzed using Kaplan-Meier method and Cox proportional hazards model.ResultsA total of 83 consecutive stage IV HGSC patients were identified. 42 (50.6%) patients were sub-classified into stage IVA with pleural effusion. Among the rest stage IVB patients, 19 (22.9%) patients had parenchymal metastases and 22 (26.5%) had extra-abdominal lymph node metastases. Five-year overall survival of stage IVA and IVB patients was 39.7% and 39.4%, respectively (p=0.711). Besides, there were no survival differences among three metastatic patterns (p=0.701).ConclusionOur study demonstrated that neither the sub-classification into FIGO IVA and IVB nor metastatic patterns of FIGO stage IV provided additional prognostic information.DisclosureNothing to disclose.
Publisher
Elsevier Inc,Elsevier Limited
Subject
